🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-526096-31-00
Completed Phase I

A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167

2026-526096-31-00 · tracked via the Priya Life Science EU tracker
Sponsor
Corteria Pharmaceuticals
Sponsor type
Pharmaceutical company
Therapeutic area
Cardiovascular Diseases
Decision date
13/05/2026
Enrollment target
20
Sites
Netherlands

Condition studied

Chronic Heart Failure

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-526096-31-00 on CTIS ↗ ← All trials in the EU